Zafirlukast - Drug Details
๐Ÿ“Š Estimates Zafirlukast Dialyzability By Different_Modalities

Zafirlukast

Complete Drug Information

Drug Name
Zafirlukast
Trade Names
Accolate
Pregnancy Category
AU: B1
Bioavailability
Unknown
Routes of Administration
Oral
Protein Binding
>99% (albumin)%
Metabolism
Hepatic (CYP2C9-mediated)
Elimination
10 hours
Excretion
Fecal
Formula
C31H33N3O6S
Molar Mass
575.68
Melting Point
138 to 140ย ยฐC
Volume of Distribution
70 L/kg

๐Ÿคฐ Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.